Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Acquisition by Nestlé  





2 Notes and references  














Nestlé Wyeth Nutrition







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Nestlé-Wyeth Nutrition (formerly owned by Pfizer after the acquisition of Wyeth in 2009) provides food products to meet the needs of infants, young children and adults. Through scientific research, they claim to help nourish children when breastfeeding is not an option. Wyeth Nutrition started in 1915 when Henry Grestberger manufactured the first formula patterned after breast milk called SMA (synthetic milk adaptive). Wyeth Pharmaceuticals, formerly Wyeth-Ayerst Laboratories, is the original company founded by the Wyeth brothers, originally known as John Wyeth and Brother. They focused on the research, development, and marketing of prescription drugs. The pharmaceuticals division was further subdivided into five subdivisions: Wyeth Research, Prescription Products, Biotech, Vaccines, and Nutritionals. Wyeth's research and development director Robert Ruffolo was quoted in The New York Times about the firm's efforts to develop new drugs.[1][2]

Acquisition by Nestlé[edit]

On 23 April 2012, Nestlé agreed to acquire Pfizer Inc.'s infant-nutrition, formerly Wyeth Nutrition, unit for US$11.9 billion, topping a joint bid from Danone and Mead Johnson.[3][4][5]

Notes and references[edit]

  1. ^ Gina kolata (March 28, 2004). "Ideas & Trends: Of Mice and Men; Why Test Animals to Cure Human Depression?". The New York Times. Retrieved 2010-12-26. But Dr. Robert R. Ruffolo, president of research and development at Wyeth,...
  • ^ Andrew pollack (June 14, 2010). "Awaiting the Genome Payoff". The New York Times. Retrieved 2010-12-26. "If on the first day we had discovered a new molecular target, it's still going to take 15 to 20 years to make the drug," said Robert R. Ruffolo Jr., who ran research and development at Wyeth until 2008.
  • ^ "Nestlé to Acquire Pfizer Baby Food Unit for $11.9 Billion". Bloomberg, 23 April 2012
  • ^ "Mead Johnson looks tasty, but Abbott may have to pass".
  • ^ "Nestlé to buy Pfizer Nutrition for $11.85bn". NewStatesman. Retrieved 5 January 2016.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Nestlé_Wyeth_Nutrition&oldid=1094515345"

    Category: 
    Nestlé
    Hidden category: 
    Pages with non-numeric formatnum arguments
     



    This page was last edited on 23 June 2022, at 02:42 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki